References
- Fattarusso Vittorio, Ritter Otto. Vadémécum clinique:
Du diagnostic au traitement-16e éd. 200 Paris. Masson. Google
Scholar
- Programme commun des Nations Unies sur le VIH/SIDA (ONUSIDA). Rapport ONUSIDA sur l'épidémie mondiale de SIDA. New York: ONUSIDA ; 2012. Google Scholar
- Brooks JT, Kaplan JE, Masur H. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections amongadults and adolescents with HIV. HIV Med. 2009;17(3):109-114. PubMed | Google Scholar
- Jeffrey Eaton, Leigh Johnson, Joshua Salomon. HIV Treatment as Prevention: SystematicComparison of MathematicalModels of the Potential Impact of AntiretroviralTherapy on HIV Incidence in South Africa. PLoS Med. 2012; 9(7): 1123- 1198. PubMed | Google Scholar
- Paiardini M, Müller-Trutwin M. HIV-associatedchronic immune activation. ImmunolRev. 2013; 254(1): 78-101. PubMed | Google Scholar
- Bassett IV, Chetty S, Giddy J, Reddy S, Bishop K, Lu Z, Losina E, Freedberg KA, Walensky RP. Screeing for acute HIV infection in South Africa: Finding acute and chronicdisease. HIV Med. 2011;12(1):46-53. PubMed | Google Scholar
- Organisation Mondiale de la Santé (OMS). Améliorer l'accès aux traitements Antirétroviraux dans les pays à ressources limitées: Recommandations pour une approche de santé publique. Genève: OMS; 2002. Google Scholar
- Jong MD, Boer RJ, Wolf F, Foudraine NA, Boucher CA, Goudsmit J, Lange JM. 0vershoot of HIV-1 viraemiaafterearly discontinuation of antiretroviraltreatment. AIDS. 1997;11(11):79-84. PubMed | Google Scholar
- Nsakala G, Coppieters Y , Kayembe P , Eloko G. Determinants associated with the practice of double STI / HIV / AIDS and teenage pregnancy among adolescents in schools in Kinshasa, DR Congo. Journal of Epidemiology and Public Health. 2013; 10: 59-72. PubMed | Google Scholar
- KatharinaKranzer ,DarshiniGovindasamy , Nathan Ford , Victoria Johnston, Stephen Lawn D. Quantifying and addressinglossesalong the continuum of care for people living with HIV infection in sub-SaharanAfrica: asystematicreview. J Int AIDS Soc. 2012; 15(2): 17383. PubMed | Google Scholar
- Wilson E, Sereti I. Immune restorationafterantiretroviraltherapy: the pitfalls of hasty or incompleterepairs. ImmunolRev. 2013; 254(1): 343-354. PubMed | Google Scholar
- Ume Abbas, Glaubius R, Mubayi A, Hood G, Mellors J. AntiretroviralTherapy
and Pre-exposureProphylaxis: Combined Impact on HIV Transmission and Drug Resistance
in South Africa. J Infect Dis. 2013; 208(2): 224-234. PubMed | Google
Scholar
- Badré-Sentenac S, Essomba C, Commeyras C, Kouanfack C, Rey JL. Utilisation du renouvellement des ordonnances d'antirétroviraux comme indicateur d'observance à Yaoundé. J Pharm Clin. 2005;24(4):225-31. PubMed | Google Scholar
- Orrell C, Wood R. Initial data on antiretroviraladherence
in Cape Town, South Africa. IAS Conf HIV PathogTreat. 2001; 1st: Abstract No
696. Google
Scholar
- Lanièce I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, Sylla O, Delaporte E, Ndoye I. Adherence to HAART and its principal determinants in a cohort of Senegaleseadults. AIDS. 2003; 17(3):103-8. PubMed | Google Scholar
- Mbopi-Kéou F-X, Dempouo Djomassi L, Monebenimp F. Etude
des facteurs liés à l'observance au traitement antirétroviral chez les patients
suivis à l?Unité de Prise En Charge du VIH/SIDA de l'Hôpital de District de
Dschang, Cameroun. The Pan AfricanMedical Journal. 2012;12:55. PubMed | Google
Scholar
- Comité National de Lutte contre le SIDA du Cameroun (CNLS). Plan Stratégique de lutte contre le VIH/SIDA au Cameroun 2011-2015. Yaoundé, CNLS 2010 ; 21p. Google Scholar
- Essomba EN, Bita A, Lehman L. Riskbehavior of HIV transmission of pupils and students in Douala, Cameroon. Mali médical. 2013; 23(4): 56-64. PubMed | Google Scholar
- Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patient compliance and drugfailure in proteaseinhibitormonotherapy. JAMA. 1996; 276(24): 1955-6. PubMed | Google Scholar
- Chkhartishvili N, Sharvadze L, Dvali N et al. Virologicoutcomes
of second-line antiretroviraltherapy in EasternEuropean country of Georgia.
AIDS Research and Therapy. 2014;11:18. PubMed | Google
Scholar
- Bessette D, Bunguener M, Costagliola D, Flori Y, Matheron
S, Morin M. L'observance aux traitements VIH/SIDA : mesure, déterminants, évolution.
2001. Paris. ARNS : P 21-32. Google
Scholar
- Kim SH, Gerver SM, Fidler S, Ward H. Adherence to antiretroviraltherapy in adolescents living with HIV: systematicreview and meta-analysis. AIDS. 2014; 28(13): 1945-56. PubMed | Google Scholar
- Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP. Adherence to highly active antiretroviraltherapies (HAART) in HIV-infected patients: fromapredictive to a dynamicapproach. Soc Sci Med. 2002; 54(10): 1481-96. PubMed | Google Scholar
- Kra O, Aba YT, Yao KH, Ouattara B, Abouo F, Tanon KA, Eholié S, Bissagnené E. Profil clinicobiologique, thérapeutique et évolutif des patients infectés par le VIH hospitalisés au service des maladies infectieuses et tropicales d'Abidjan. Bull Soc patholexot. 2012; 106(1): 37-42. PubMed | Google Scholar
- Siu GE, Wight D, Seeley J. Dented and 'resuscitatedmasculinities: the impact of HIV diagnosis and/or enrolment on antiretroviraltreatment on masculine identities in rural eastern Uganda. Sahara J. 2014; 11(1): 211-21. PubMed | Google Scholar
- Folefack Tengomo G. Les déterminants de la non observance à la
thérapie antirétrovirale par les patients adultes infectés par le VIH et suivis
au CHU de Cotonou. IRSP. 2003; 4(8) : 112- 146. PubMed | Google
Scholar
- Comité National de Lutte contre le SIDA (CNLS). Rapport
annuel 2011 des activités de lutte contre le VIH, SIDA et les IST au Cameroun.
Yaoundé: CNLS, 2012. Google
Scholar
- Oumar AA, Dao S, Diamoutene A, Coulibaly S, Koumare B, Maiga II, Mariko E. Factors associated with antiretroviral treatment observance at Point “G”hospital. Mali Med. 2007; 22(1):18-21. PubMed | Google Scholar
- Oku AO, Owoaje ET, Ige OK, Oyo-ita A. Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiaryhealthfacility in south-south Nigeria. BMC InfectiousDiseases. 2013;13(1):401. PubMed | Google Scholar
- Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuringmedicationadherence in research. AIDS Behav. 2013; 17(1): 284-297. PubMed | Google Scholar
- Sharma S, Khadga P, Dhungana GP, Chitrakar U. Medicationadherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan University Teaching Hospital, Kathmandu Nepal. Kathmandu Univ .Med J (KUMJ). 2013;11 (41):50-3. PubMed | Google Scholar
- Finitsis DJ, Pellowski JA, Johnson BT. Text Message Intervention Designs to PromoteAdherence to AntiretroviralTherapy (ART): A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2014; 9(2): 88166. PubMed | Google Scholar
- Duran S, Solas C, Spire B, Carrieri MP, Fuzib JG, Costagliola D. Do HIV-infected injecting drug users over-report adherence to highly active antiretroviraltherapy' A comparison between patients'self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohortstudy. AIDS. SIDA. 2001; 15 (8): 1075-7. PubMed | Google Scholar
- Azmeraw D, Wasie B. Factors associated with adherence to highly active antiretrovira ltherapy among children in two referral hospitals, northwestEthiopia. Ethiop Med J. 2012; 50(2):115-24. PubMed | Google Scholar
- Emamzadeh-Fard S, Fard SE, Seyed Alinaghi S, Paydary K. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: areview. Infect Disord Drug Targets. 2012;12(5):346-56. PubMed | Google Scholar